Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Hai-Nan Zhang and Shu-Juan Guo.
Connection Strength

0.468
  1. Nsp2 has the potential to be a drug target revealed by global identification of SARS-CoV-2 Nsp2-interacting proteins. Acta Biochim Biophys Sin (Shanghai). 2021 Aug 31; 53(9):1134-1141.
    View in: PubMed
    Score: 0.060
  2. Systematic profiling of SARS-CoV-2-specific IgG responses elicited by an inactivated virus vaccine identifies peptides and proteins for predicting vaccination efficacy. Cell Discov. 2021 Aug 17; 7(1):67.
    View in: PubMed
    Score: 0.060
  3. Antibody landscape against SARS-CoV-2 reveals significant differences between non-structural/accessory and structural proteins. Cell Rep. 2021 07 13; 36(2):109391.
    View in: PubMed
    Score: 0.060
  4. Linear epitope landscape of the SARS-CoV-2 Spike protein constructed from 1,051 COVID-19 patients. Cell Rep. 2021 03 30; 34(13):108915.
    View in: PubMed
    Score: 0.058
  5. Systematic profiling of SARS-CoV-2-specific IgG epitopes at amino acid resolution. Cell Mol Immunol. 2021 04; 18(4):1067-1069.
    View in: PubMed
    Score: 0.058
  6. Systematic evaluation of IgG responses to SARS-CoV-2 spike protein-derived peptides for monitoring COVID-19 patients. Cell Mol Immunol. 2021 03; 18(3):621-631.
    View in: PubMed
    Score: 0.058
  7. Antibody dynamics to SARS-CoV-2 in asymptomatic COVID-19 infections. Allergy. 2021 02; 76(2):551-561.
    View in: PubMed
    Score: 0.057
  8. Linear epitopes of SARS-CoV-2 spike protein elicit neutralizing antibodies in COVID-19 patients. Cell Mol Immunol. 2020 10; 17(10):1095-1097.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.